The Tarceva is still doing its job in there. I had an MRI that looked just like the last one, which is completely clear. Blood work was mostly normal and was similar to prior reports. Good news overall.
When we were back at home tonight, I received a text message from Irene, our oncology nurse, that said a press release came out on Sunday that Merck has filed with the FDA for their drug, Keytruda to treat melanoma and lung cancer. This is one of the immunotherapy drugs we’ve been watching and waiting to get approved. I’ve attached a link to a Wall Street Journal article with the press release. http://www.wsj.com/articles/mercks-keytruda-shows-improved-survival-odds-for-melanoma-patients-1429448169 . This has a LOT of promise. It is possible I might be able to go on this (or one of the rival drugs that other Rx companies are developing that are similar) sometime midyear. Cross your fingers! J
